Raytheon Technologies Corp vs Veeva Systems — how do they compare? Raytheon Technologies Corp trades at $185.97 (market cap $248.42B), while Veeva Systems trades at $296.13 (market cap $46.12B). The key difference: Raytheon Technologies Corp is far larger — about 5.4× Veeva Systems's market cap, and Raytheon Technologies Corp pays a 1.58% dividend while Veeva Systems pays none. Which is the better fit depends on your goals — on Pluang, investors hold Raytheon Technologies Corp for 77 Days and Veeva Systems for 6 Days on average.
| RTX | VEEV | |
|---|---|---|
Market Cap | $248.42B | $46.12B |
Volume | 4,380,368 | 921,537 |
Sector | Industrials | Technology |
52-Week High | $225.49 | $299.10 |
52-Week Low | $157.00 | $151.43 |
Typical Hold Time | 77 Days | 6 Days |
Enterprise Value | $278.97B | $39.03B |
Dividend Yield | 1.58% | — |
Signals from Pluang's Aura AI — not financial advice
RTX trades at $184.32, up 2.25% with strong earnings momentum as Q1 and Q2 2026 results beat expectations. The stock shows bearish technical signals but benefits from a $289 billion backlog and rising defense spending. Revenue grew to $88.6 billion in 2025 with net income of $6.73 billion, while analyst consensus remains bullish with a $236.27 price target.
Outlook is positive given defense budget tailwinds and operational execution, though technical weakness and debt levels pose risks. The company's dividend and backlog provide stability, but investors should monitor geopolitical impacts and interest rate sensitivity.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Raytheon Technologies is a diversified aerospace and defense industrial company formed from the merger of United Technologies and Raytheon, with roughly equal exposure as a supplier to commercial aerospace manufactures and to the defense market as a prime and subprime contractor.
Read more on RTX →Veeva Systems provides cloud software, data, and services for the life sciences industry. Its applications support functions across clinical research, regulatory operations, quality, safety, and commercial teams.
Read more on VEEV →